Daily serum creatinine monitoring promotes earlier detection of acute kidney injury in children and adolescents with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 13, Issue 4, 2014, Pages 435-441

  Downes, Kevin J ^a   Rao, Marepalli B ^b   Kahill, Laurie ^a   Nguyen, Hovi ^a   Clancy, John P ^a   Goldstein, Stuart L ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Acute kidney injury; Aminoglycosides; Cystic fibrosis; Drug monitoring; Tobramycin

Indexed keywords

AMIKACIN; CEFTAZIDIME; CLAVULANIC ACID; CREATININE; NONSTEROID ANTIINFLAMMATORY AGENT; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TOBRAMYCIN; VANCOMYCIN; AMINOGLYCOSIDE;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADOLESCENT DISEASE; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL OBSERVATION; COHORT ANALYSIS; CREATININE BLOOD LEVEL; CYSTIC FIBROSIS; DRUG MONITORING; EARLY DIAGNOSIS; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL PATIENT; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; RETROSPECTIVE STUDY; SURVIVAL TIME; ACUTE KIDNEY INJURY; BLOOD; CHEMICALLY INDUCED; FOLLOW UP; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION TEST; PHYSIOLOGIC MONITORING; PROCEDURES; RISK FACTOR; YOUNG ADULT;

ACUTE KIDNEY INJURY; ADOLESCENT; AMINOGLYCOSIDES; CHILD; CREATININE; CYSTIC FIBROSIS; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FUNCTION TESTS; MALE; MONITORING, PHYSIOLOGIC; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84902357306     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2014.03.005     Document Type: Article

References (30)

1. Hui-Stickle S., Brewer E.D., Goldstein S.L. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 2005, 45(1):96-101.
2. Rougier F., Claude D., Maurin M., Maire P. Aminoglycoside nephrotoxicity. Curr Drug Targets Infect Disord 2004, 4(2):153-162.
3. Zappitelli M., Moffett B.S., Hyder A., Goldstein S.L. Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study. Nephrol Dial Transplant 2011, 26(1):144-150.
4. Askenazi D.J., Feig D.I., Graham N.M., Hui-Stickle S., Goldstein S.L. 3-5year longitudinal follow-up of pediatric patients after acute renal failure. Kidney int 2006, 69(1):184-189.
5. Abitbol C.L., Bauer C.R., Montane B., Chandar J., Duara S., Zilleruelo G. Long-term follow-up of extremely low birth weight infants with neonatal renal failure. Pediatr Nephrol 2003, 18(9):887-893.
6. Coca S.G., Singanamala S., Parikh C.R. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int Mar 2012, 81(5):442-448.
7. Wehbe E., Brock R., Budev M., Xu M., Demirjian S., Schreiber M.J., et al. Short-term and long-term outcomes of acute kidney injury after lung transplantation. J Heart Lung Transplant Mar 2012, 31(3):244-251.
8. Chertow G.M., Burdick E., Honour M., Bonventre J.V., Bates D.W. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005, 16(11):3365-3370.
9. Price J.F., Mott A.R., Dickerson H.A., Jefferies J.L., Nelson D.P., Chang A.C., et al. Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome?. Pediatr Crit Care Med 2008, 9(3):279-284.
10. Blinder J.J., Goldstein S.L., Lee V.V., Baycroft A., Fraser C.D., Nelson D., et al. Congenital heart surgery in infants: effects of acute kidney injury on outcomes. J Thorac Cardiovasc Surg 2012, 143(2):368-374.
11. Moffett B.S., Goldstein S.L. Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin J Am Soc Nephrol 2011, 6(4):856-863.
12. Srisawat N., Hoste E.E., Kellum J.A. Modern classification of acute kidney injury. Blood Purif 2010, 29(3):300-307.
13. Bertenshaw C., Watson A.R., Lewis S., Smyth A. Survey of acute renal failure in patients with cystic fibrosis in the UK. Thorax 2007, 62(6):541-545.
14. Samaniego-Picota M.D., Whelton A. Aminoglycoside-induced nephrotoxicity in cystic fibrosis: a case presentation and review of the literature. Am J Ther 1996, 3(3):248-257.
15. Al-Aloul M., Miller H., Stockton P., Ledson M.J., Walshaw M.J. Acute renal failure in CF patients chronically infected by the Liverpool epidemic Pseudomonas aeruginosa strain (LES). J Cyst Fibros 2005, 4(3):197-201.
16. Benden C. CR5/20-Acute renal failure in a child with cystic fibrosis awaiting lung transplantation-a good outcome after all. Paediatr Respir Rev 2006, 7(Suppl. 1):S327.
17. Drew J., Watson A.R., Smyth A. Acute renal failure and cystic fibrosis. Arch Dis Child 2003, 88(7):646.
18. Kennedy S.E., Henry R.L., Rosenberg A.R. Antibiotic-related renal failure and cystic fibrosis. J Paediatr Child Health 2005, 41(7):382-383.
19. Smyth A., Lewis S., Bertenshaw C., Choonara I., McGaw J., Watson A. Case-control study of acute renal failure in patients with cystic fibrosis in the UK. Thorax 2008, 63(6):532-535.
20. Florescu M.C., Lyden E., Murphy P.J., Florescu D.F., Fillaus J. Long-term effect of chronic intravenous and inhaled nephrotoxic antibiotic treatment on the renal function of patients with cystic fibrosis. Hemodial Int 2012, 16(3):414-419.
21. Al-Aloul M., Miller H., Alapati S., Stockton P.A., Ledson M.J., Walshaw M.J. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatr Pulmonol 2005, 39(1):15-20.
22. Al-Aloul M., Jackson M., Bell G., Ledson M., Walshaw M. Comparison of methods of assessment of renal function in cystic fibrosis (CF) patients. J Cyst Fibros 2007, 6(1):41-47.
23. Goldstein S.L., Kirkendall E., Nguyen H., Schaffzin J.K., Bucuvalas J., Bracke T., et al. Electronic Health Record Identification of Nephrotoxin Exposure and Associated Acute Kidney Injury. Pediatrics Sep 2013, 132(3):e756-767.
24. Khwaja A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron Clin Pract 2012, 120(4):179-184.
25. Lacy C., Armstrong L., Goldman M., Lance L. Drug Information Handbook 2009, Lexi-Comp, Inc., Hudson, Ohio. 16th ed.
26. Wang X., Dockery D.W., Wypij D., Fay M.E., Ferris B.G. Pulmonary function between 6 and 18years of age. Pediatr Pulmonol 1993, 15(2):75-88.
27. Hankinson J.L., Odencrantz J.R., Fedan K.B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999, 159(1):179-187.
28. Hedges L., Olkin I. Statistical Method for Meta-Analysis 1985, Academic Press, Salt Lake City. First ed.
29. Harris P.A., Taylor R., Thielke R., Payne J., Gonzalez N., Conde J.G. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009, 42(2):377-381.
30. Pfaller W., Gstraunthaler G. Nephrotoxicity testing in vitro-what we know and what we need to know. Environ Health Perspect 1998, 106(Suppl. 2):559-569.